Abdul, Moried R.
HRN: 23-43-21 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/14/2025
12/21/2025
IV
425MG
Q6
URTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes